Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction

被引：0
|
作者：
Rodney A. Appell
机构：
来源：
Current Urology Reports | 2006年 / 7卷 / 5期
关键词：
Urinary Retention; Lower Urinary Tract Symptom; Overactive Bladder; Detrusor Overactivity; Tolterodine;
D O I：
10.1007/s11934-006-0015-z
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：429 / 429
相关论文
共 50 条
  • [41] Safety and Tolerability Profiles of Anticholinergic Agents Used for the Treatment of Overactive Bladder
    Michael G. Oefelein
    Drug Safety, 2011, 34 : 733 - 754
  • [42] Efficacy of fesoterodine compared with extended-release tolterodine in men and women with overactive bladder
    Ginsberg, David
    Schneider, Tim
    Kelleher, Con
    Van Kerrebroeck, Philip
    Swift, Steven
    Creanga, Dana
    Martire, Diane L.
    BJU INTERNATIONAL, 2013, 112 (03) : 373 - 385
  • [43] Tolterodine offers new hope for those with overactive bladder
    不详
    Drugs & Therapy Perspectives, 1999, 13 (6) : 1 - 4
  • [44] Treatment of the overactive bladder with tolterodine, a new muscarinic receptor antagonist
    Messelink, EJ
    BJU INTERNATIONAL, 1999, 83 : 48 - 52
  • [45] The overactive bladder in children:: a potential future indication for tolterodine
    Hjälmås, K
    Hellström, AL
    Mogren, K
    Läckgren, G
    Stenberg, A
    BJU INTERNATIONAL, 2001, 87 (06) : 569 - 574
  • [46] Clinical and urodynamic effects of tolterodine in women with an overactive bladder
    Wang, Chiu-Lin
    Wu, Chin-Hu
    Liu, Cheng-Min
    Shen, Ching-Ju
    Lin, Kun-Ling
    Long, Cheng-Yu
    TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY, 2013, 52 (03): : 381 - 384
  • [47] Mirabegron in Overactive Bladder: A Review of Efficacy, Safety, and Tolerability
    Chapple, Christopher R.
    Cardozo, Linda
    Nitti, Victor W.
    Siddiqui, Emad
    Michel, Martin C.
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (01) : 17 - 30
  • [48] Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome
    Abrams, Paul
    Cardozo, Linda
    Chapple, Christopher
    Serdarevic, Dzelal
    Hargreaves, Katherine
    Khullar, Vikram
    INTERNATIONAL JOURNAL OF UROLOGY, 2006, 13 (06) : 692 - 698
  • [49] Effects of tolterodine extended release on patient perception of bladder condition and overactive bladder symptoms
    Herschorn, Sender
    Heesakkers, John
    Castro-Diaz, David
    Wang, Joseph T.
    Brodsky, Marina
    Guan, Zhonghong
    CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (12) : 3513 - 3521
  • [50] Tolterodine extended-release for overactive bladder
    Chung, Doreen E.
    Te, Alexis E.
    EXPERT OPINION ON PHARMACOTHERAPY, 2009, 10 (13) : 2181 - 2194
12345